Prophylaxis with gentamicin locking of chronic tunneled central venous catheter does not cause bacterial resistance;La profilaxis con sellado de gentamicina de las ramas del catéter venoso central crónico tunelizado no causa resistencia bacteriana

Nefrologia

Volumn 31, Issue 3, 2011, Pages 308-312

  Fernandez Gallego J ^a   Martin M ^a   Gutierrez E ^a   Cobelo, C ^a   Frias P ^a   Jironda, C ^a   Hidalgo, P ^a   Jimenez T ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Bacteremia; Catheter; Gentamicin; Gentamicin bacterial resistance; Hemodialysis; Prophylaxis

Indexed keywords

ANTIINFECTIVE AGENT; GENTAMICIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; FEMALE; HUMAN; INSTRUMENTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; DRUG RESISTANCE, BACTERIAL; FEMALE; GENTAMICINS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; YOUNG ADULT;

EID: 79958249712     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2011.Feb.10257     Document Type: Article

References (24)

1. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 2001;60: 1443-51.
2. Pastan S, Michael Sousie J, Mc Clellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int 2002;62:620-6.
3. Fernández-Gallego J, López V, Martín MA, Toledo R. El catéter venoso central crónico tunelizado aumenta la mortalidad en hemodiálisis. Nefrologia 2005;25:720-1.
4. Nassar GM, Ayus JC. Infectious complications of the hemodialysis access. Kidney Int 2001;60:1-13.
5. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999;284:1318-22.
6. Fernández-Gallego J, Alonso A, Sujan S, Gutiérrez E. La profilaxis con gentamicina disminuye la morbi-mortalidad infecciosa bacteriana causada por el catéter venoso central permanente tunelizado. Nefrologia 2007;27:228-30.
7. Dogra GK, Herson H, Hutchison B, Irisk AB, Heath CH, Golled HC, et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with of gentamicin and citrate: a randomized control study. J Am Soc Nephrol 2002;3:2133-9.
8. Hernández-Jaras J, García-Pérez E, Torregrosa E, Pons R, Calvo C, Serra M, et al. Seguimiento a largo plazo de catéteres permanentes en pacientes con dificultad en la obtención de un acceso vascular definitivo. Nefrologia 2004;24:446-52.
9. McIntyre CW, Hulme LJ, Taal M, Fluch RJ. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int 2004;66:801-5.
10. Saxena AK, Panhotra BR. Locking hemodialysis catheters with cefotaxime instead of gentamicin to avoid potential ototoxicity. Kidney Int 2005;67:2505-6.
11. Saxena AK, Panthotra BR, Sundaram DS, Al-Hafiz A, Naguib M, Venkateshappa CK, et al. Tunneled catheters outcome optimization among diabetics on dialysis through antibiotic-lock placement. Kidney Int 2006;70:1629-36.
12. Labriola L, Crott R, Jadoul M. Preventing haemodialysis catheterrelated bacteraemia with an antimicrobian lock solution: A metaanalysis of prospective randomized trials. Nephrol Dial Transplant 2008;23:1666-72.
13. Jaffer Y, Selby NM, Taal MW, Fluck RJ, McIntyre CW. A metaanalysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis 2008;51:233-41.
14. Jamey MT, Cooley J, Tonelli M, Manus BJ, MacRae J, Hemmelgarn BR, Alberta Kidney Disease Network. Meta-analysis: Antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med 2008;148:596-605.
15. Yahav D, Rosen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: Sistematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 2008;47:83-93.
16. Kannaiyan SR, Tarun B, Ruma D, Ranjit SH, MacLeod AM, Moore C, et al. Systematic review of antimicrobials for the prevention of haemodialysis catheter-related infections. Nephrol Dial Transplant 2009;24:3763-74.
17. Vanholder R, Canaud B, Fluck R, Jadoul M, Labriola L, Marti-Monros J, et al. Diagnosis, prevention and treatment of haemodialysis catheterrelated bloodstream infections (CRBSI): a position statement of European Renal Best Practice (ERBP). NDT Plus 2010;3:234-46.
18. Beathard GA, Urbanes A. Infection associated with tunneled hemodialysis catheter. Semin Dial 2008;21:528-38.
19. NKF K/DOQI Guidelines. Clinical practice guidelines for vascular access: Guidelines 7: Prevention and treatment of catheter and port complications. Am J Kidney Dis 2006;48(Suppl 1):S176-S247.
20. Gilbert DN. Aminoglycosides. En: Mandel GL, Bennet JE, Dolin R (eds.). Principles and practice of infectious diseases. Philadelphia: Churchill Livingstone, 1995;279-306.
21. Negishi K, Efrati S, Eviatar E, Abramsohn R, Yarovoy I, Gersch E, et al. Gentamicin-induced ototoxicyty in hemodialysis patients is ameliorated by N-acetylcysteine. Kidney Int 2007;72:359-64.
22. Landry DL, Braden GL, Gobeille SL, Haessler SD, Vaidya ChK, Sweet SJ. Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol 2010;5:1799-804.
23. Gruss E, Portolés J, Caro P, Merino JL, López-Sánchez P, Tato A, et al. Los modelos de atención al acceso vascular condicionan resultados heterogéneos en los centros de una misma comunidad. Nefrologia 2010;30:310-6.
24. Albalate M, Pérez García R, De Sequera P, Alcázar R, Puerta M, Ortega M, Mossé A, et al. ¿Hemos olvidado lo más importante para prevenir las bacteriemias en pacientes portadores de catéteres para hemodiálisis? Nefrologia 2010;30:573-7.